Bioluminescence imaging of stem cell-based therapeutics for vascular regeneration

Theranostics

Volumn 2, Issue 4, 2012, Pages 346-354

  Huang, Ngan F ^a   Okogbaa, Janet ^a   Babakhanyan, Anna ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioluminescence; Embryonic stem cell; Induced pluripotent stem cell; Myocardial infarction; Peripheral arterial disease; Vascular regeneration

Indexed keywords

ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ANGIOGENESIS; APOPTOSIS; BIOLUMINESCENCE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CELL VIABILITY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; EXPERIMENTAL MODEL; FETAL STEM CELL; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; LIMB PERFUSION; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR DISEASE;

EID: 84864558864     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3694     Document Type: Review

References (49)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145-7
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76
3. Strauss S. Geron trial resumes, but standards for stem cell trials remain elusive. Nat Biotechnol. 2010; 28: 989-90.
4. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol. 2011; 13: 497-505.
5. Ye L, Chang JC, Lin C, Sun X, Yu J, Kan YW. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A. 2009; 106: 9826-30
6. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007; 318: 1920-3.
7. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A. 2008; 105: 5856-61.
8. Ramos-Mejia V, Munoz-Lopez M, Garcia-Perez JL, Menendez P. iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res. 2010; 20: 1092-5.
9. Phanstiel DH, Brumbaugh J, Wenger CD, Tian S, Probasco MD, Bailey DJ, et al. Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods. 2011; 8: 821-7.
10. Christodoulou C, Longmire TA, Shen SS, Bourdon A, Sommer CA, Gadue P, et al. Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes. J Clin Invest. 2011; 121: 2313-25.
11. Pera MF. Stem cells: The dark side of induced pluripotency. Nature. 2011; 471: 46-7.
12. Rufaihah AJ, Huang NF, Jame S, Lee JC, Nguyen HN, Byers B, et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2011; 31: e72-9.
13. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, et al. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011; 471: 58-62.
14. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006; 119: 2204-13.
15. Madonna R, Geng YJ, De Caterina R. Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arterioscler Thromb Vac Biol. 2009; 29: 1723-9.
16. Chekanov V, Akhtar M, Tchekanov G, Dangas G, Shehzad MZ, Tio F, et al. Transplantation of autologous endothelial cells induces angiogenesis. Pacing Clin Electrophysiol. 2003; 26: 496-9.
17. Kim EJ, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, et al. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg. 2001; 122: 963-71.
18. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010; 142: 375-86.
19. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010; 463: 1035-41.
20. Lasala GP, Minguell JJ. Vascular disease and stem cell therapies. Br Med Bull. 2011; 98: 187-97.
21. Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vac Biol. 2008; 28: 208-16.
22. Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011; 58: 1095-104.
23. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004; 109: 1615-22.
24. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001; 89: E1-7.
25. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell stem cell. 2010; 7: 618-30.
26. Luker GD, Luker KE. Optical imaging: current applications and future directions. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 2008; 49: 1-4.
27. Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, et al. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PloS one. 2010; 5: e9364.
28. Kadurugamuwa JL, Modi K, Coquoz O, Rice B, Smith S, Contag PR, et al. Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response. Infect Immun. 2005; 73: 7836-43.
29. Venisnik KM, Olafsen T, Gambhir SS, Wu AM. Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging. Mol Imaging Biol. 2007; 9: 267-77.
30. Pichler A, Prior JL, Piwnica-Worms D. Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci U S A. 2004; 101: 1702-7.
31. Loening AM, Wu AM, Gambhir SS. Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat Methods. 2007; 4: 641-3.
32. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol. 1995; 18: 593-603.
33. Graves EE, Ripoll J, Weissleder R, Ntziachristos V. A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys. 2003; 30: 901-11.
34. Hickson J. In vivo optical imaging: preclinical applications and considerations. Urologic oncology. 2009; 27: 295-7.
35. Kormann MS, Hasenpusch G, Aneja MK, Nica G, Flemmer AW, Herber-Jonat S, et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol. 2011; 29: 154-7.
36. Lee MS, Kwon EH, Choi HS, Kwon SH, Lee CH, Shim IS, et al. Quantification of cellular uptake and in vivo tracking of transduction using real-time monitoring. Biochem Biophys Res Commun. 2010; 394: 348-53.
37. Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, et al. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res. 2010; 106: 1904-11.
38. Hoffmann J, Glassford AJ, Doyle TC, Robbins RC, Schrepfer S, Pelletier MP. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia. The Thoracic and cardiovascular surgeon. 2010; 58: 136-42.
39. Laurila JP, Laatikainen L, Castellone MD, Trivedi P, Heikkila J, Hinkkanen A, et al. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy. 2009; 11: 726-37.
40. Sanz L, Santos-Valle P, Alonso-Camino V, Salas C, Serrano A, Vicario JL, et al. Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc Res. 2008; 75: 308-14.
41. Bai X, Yan Y, Song YH, Seidensticker M, Rabinovich B, Metzele R, et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J. 2010; 31: 489-501.
42. Bai X, Yan Y, Coleman M, Wu G, Rabinovich B, Seidensticker M, et al. Tracking long-term survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging. Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging. 2011; 13: 633-45.
43. Huang NF, Niiyama H, Peter C, De A, Natkunam Y, Fleissner F, et al. Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol. 2010; 30: 984-91.
44. Rufaihah AJ, Huang NF, Jame S, Lee J, Nguyen HN, Byers B, et al. Endothelial Cells Derived From Human iPSCS Increase Capillary Density and Improve Perfusion in A Mouse Model of Peripheral Arterial Disease. Arterioscler Thromb Va c Biol. 2011 Nov;31(11):e72-9.
45. Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation. 2007; 116: I46-54.
46. Li Z, Wilson KD, Smith B, Kraft DL, Jia F, Huang M, et al. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PloS one. 2009; 4: e8443.
47. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001; 7: 833-9.
48. Yu J, Huang NF, Wilson KD, Velotta JB, Huang M, Li Z, et al. nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis. PLoS One. 2009; 4: e7040.
49. Tang C, Lee AS, Volkmer JP, Sahoo D, Nag D, Mosley AR, et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol. 2011; 29: 829-34.